Market Sentiment Around Loss-Making Geron Corporation (NASDAQ:GERN) - simplywall.st
4 weeks ago • Google News
Geron Corporation (GERN)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 867.7M
P/E Ratio
0.00
Revenue (TTM)
$ 164.45M
Volume
0
52W High
$ 4.83
52W Low
$ 1.09
Dividend Yield
0.00%
Beta
0.73
Technicals
50-Day MA
1.3874
200-Day MA
2.318
52 Week High
4.825
52 Week Low
1.09
About GERN
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult pat.
Employees
229
Headquarters
Foster City, CA
CEO
Ms. Michelle J. Robertson
Latest News
Geron: I Think We've Seen This Movie Before (NASDAQ:GERN) - Seeking Alpha
4 days ago • Google News
Geron (GERN.O) Surges 9.375% — What’s Behind the Sharp Move? - AInvest
Yesterday • Google News